Concentric Capital Strategies’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.78M Sell
25,748
-4,819
-16% -$701K 0.21% 107
2026
Q1
$4.42M Buy
+30,567
New +$4.63M 0.37% 40
2025
Q4
– Sell
-2,890
Closed -$444K – 360
2025
Q3
$444K Buy
2,890
+40
+1% +$6.25K 0.02% 270
2025
Q2
$454K Buy
+2,850
New +$465K 0.02% 250
2025
Q1
– Sell
-2,139
Closed -$359K – 268
2024
Q4
$359K Buy
+2,139
New +$364K 0.02% 234

Other funds holding PG

Concentric Capital Strategies's PG Position: Q2 2026 in Review

Concentric Capital Strategies reduced its Procter & Gamble (PG) stake by 16% in Q2 2026, selling an estimated $701K and leaving 25,748 shares worth $3.78M. The position accounts for 0.21% of the portfolio, ranked #107.

Concentric Capital Strategies first reported a position in PG in Q4 2024 and has held it in 5 quarters since. The position peaked at $4.42M in Q1 2026. 4,041 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Concentric Capital Strategies held 25,748 shares of Procter & Gamble worth $3.78M as of Q2 2026.
  • Concentric Capital Strategies sold 4,819 Procter & Gamble shares in Q2 2026, an estimated $701K.
  • Procter & Gamble made up 0.21% of Concentric Capital Strategies's portfolio in Q2 2026, its #107 holding.
  • Concentric Capital Strategies first reported a position in Procter & Gamble in Q4 2024 and has held it in 5 quarters since.
  • Concentric Capital Strategies's Procter & Gamble position peaked at $4.42M in Q1 2026.
  • 4,041 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.